Prostate Specific Antigen as an Outcome Variable for T1 and T2 Prostate Cancer Treated by Radiation Therapy
Author:
Affiliation:
1. From the Department of Radiotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference21 articles.
1. Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy;Zagars;Int. J. Rad. Oncol. Biol. Phys.,1992
2. Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer;Ritter;J. Clin. Oncol.,1992
3. Prostate-specific anti gen. An important marker for prostate cancer treated by external beam radiotherapy;Zagars;Cancer,1993
4. Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer;Pisansky;J. Clin. Oncol.,1993
5. Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy;Russell;J. Urol.,1991
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ROLE OF KINETIC PERFORMANCE OF PSA IN SELECTION OF THE PATIENTS FOR CONDUCTION OF ¹¹C-CHOLINE PET/CT AIMED TO REVEAL LOCAL RECURRENCES OF PROSTATE CANCER;Grekov's Bulletin of Surgery;2015-12-28
2. PSA Nadir of <0.5 ng/mL Following Brachytherapy for Early-Stage Prostate Adenocarcinoma is Associated With Freedom From Prostate-Specific Antigen Failure;International Journal of Radiation Oncology*Biology*Physics;2012-06
3. Outcomes for intermediate risk prostate cancer: Are there advantages for surgery, external radiation, or brachytherapy?;Urologic Oncology: Seminars and Original Investigations;2009-01
4. Best practice in primary care pathology: review 4;Journal of Clinical Pathology;2006-09-01
5. The two-week-wait cancer initiative in urology: useful modernization?;JRSM;2004-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3